Mirjana Kujacic
AstraZeneca
7
0
7
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Kelli Craven, MD
Quintiles, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Ken Price
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Stanko Skrtic
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Aslak Rautio
Quintiles Hermelinen AB
Shared therapeutic areas:
Worked with same sponsors:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Wolfgang Kuhn
Quintiles AB
Shared therapeutic areas:
Worked with same sponsors:
Folke Sjöberg
J.J. Berzelius Clinical Research Center AB
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin
Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients
Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients
Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel
Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg
All 7 trials loaded